Onychomycosis Treatment Market to Raise at a CAGR of over 6.7% During 2018–2028: Medimetriks Pharmaceuticals, Inc., Lumenis Ltd., Biofrontera AG, and Leo Pharma A/S
Accounting for approximately 12% of the entire fungal infection treatments space, onychomycosis treatment has been witnessing a high prevalence-low awareness scenario over the years. However, gradually increasing awareness about the potential threats of onychomycosis and growing availability of treatments for the condition clearly point to a promising outlook for onychomycosis treatment market over the course of coming years.
View full press release